BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24293060)

  • 1. A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.
    Löbbe AM; Kang JS; Hilker R; Hackstein H; Müller U; Nolte D
    J Mol Neurosci; 2014 Apr; 52(4):493-6. PubMed ID: 24293060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.
    Chiang HL; Fuh JL; Tsai YS; Soong BW; Liao YC; Lee YC
    J Neurol Sci; 2021 Sep; 428():117600. PubMed ID: 34333379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
    Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
    Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation.
    Edener U; Wöllner J; Hehr U; Kohl Z; Schilling S; Kreuz F; Bauer P; Bernard V; Gillessen-Kaesbach G; Zühlke C
    Eur J Hum Genet; 2010 Aug; 18(8):965-8. PubMed ID: 20354562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
    Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
    Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
    Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
    PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.
    Musova Z; Kaiserova M; Kriegova E; Fillerova R; Vasovcak P; Santava A; Mensikova K; Zumrova A; Krepelova A; Sedlacek Z; Kanovsky P
    Cerebellum; 2014 Jun; 13(3):331-7. PubMed ID: 24272953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.
    Cagnoli C; Stevanin G; Brussino A; Barberis M; Mancini C; Margolis RL; Holmes SE; Nobili M; Forlani S; Padovan S; Pappi P; Zaros C; Leber I; Ribai P; Pugliese L; Assalto C; Brice A; Migone N; Dürr A; Brusco A
    Hum Mutat; 2010 Oct; 31(10):1117-24. PubMed ID: 20725928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.
    Szpisjak L; Nemeth VL; Szepfalusi N; Zadori D; Maroti Z; Kalmar T; Vecsei L; Klivenyi P
    Cerebellum; 2017 Dec; 16(5-6):979-985. PubMed ID: 28660440
    [No Abstract]   [Full Text] [Related]  

  • 10. SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.
    Svenstrup K; Nielsen TT; Aidt F; Rostgaard N; Duno M; Wibrand F; Vinther-Jensen T; Law I; Vissing J; Roos P; Hjermind LE; Nielsen JE
    Cerebellum; 2017 Feb; 16(1):62-67. PubMed ID: 26868664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 28 in a Chinese pedigree: A case report and literature review.
    Liu X; Wang L; Chen J; Kang C; Li J
    Medicine (Baltimore); 2021 Dec; 100(50):e28008. PubMed ID: 34918652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
    Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
    Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spastic ataxia with eye-of-the-tiger-like sign in 4 siblings due to novel compound heterozygous AFG3L2 mutation.
    Calandra CR; Buda G; Vishnopolska SA; Oliveri J; Olivieri FA; Pérez Millán MI; Biagioli G; Miquelini LA; Pellene AL; Marti MA
    Parkinsonism Relat Disord; 2020 Apr; 73():52-54. PubMed ID: 32248051
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
    Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
    Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
    Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
    J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel AFG3L2 mutation in a Somalian patient with spinocerebellar ataxia type 28.
    Qu J; Wu CK; Zuzuárregui JR; Hohler AD
    J Neurol Sci; 2015 Nov; 358(1-2):530-1. PubMed ID: 26454370
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinocerebellar ataxia type 28 (SCA28) is an uncommon cause of dominant ataxia among Chinese kindreds.
    Jia D; Tang B; Chen Z; Shi Y; Sun Z; Zhang L; Wang J; Xia K; Jiang H
    Int J Neurosci; 2012 Oct; 122(10):560-2. PubMed ID: 22563911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28.
    Smets K; Deconinck T; Baets J; Sieben A; Martin JJ; Smouts I; Wang S; Taroni F; Di Bella D; Van Hecke W; Parizel PM; Jadoul C; De Potter R; Couvreur F; Rugarli E; De Jonghe P
    Neurology; 2014 Jun; 82(23):2092-100. PubMed ID: 24814845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis.
    Mariotti C; Brusco A; Di Bella D; Cagnoli C; Seri M; Gellera C; Di Donato S; Taroni F
    Cerebellum; 2008; 7(2):184-8. PubMed ID: 18769991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
    Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
    Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.